Schedule 13G ownership disclosure

Treace Medical Concepts Inc

Common stock, $0.001 par value · CUSIP: 89455T109

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Gagnon Securities LLC

    Shares: 3,928,051.00 · Class: 6.2%

  • Gagnon Advisors, LLC

    Shares: 1,534,034.00 · Class: 2.4%

  • Neil Gagnon

    Shares: 6,142,107.00 · Class: 9.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-26-000033
Form type
SCHEDULE 13G/A
Filer
GAGNON SECURITIES LLC
CIK
CIK 1125725
Filed
Feb 12, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub